Journal article

In adults with BMI ≥27 kg/m2 and CVD, but without diabetes, semaglutide reduced MACE, regardless of baseline HbA1c level

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Zhu, D., & Herrington, W. G. (2024). In adults with BMI ≥27 kg/m2 and CVD, but without diabetes, semaglutide reduced MACE, regardless of baseline HbA1c level. Annals of Internal Medicine, 177(11).

MLA Style

Zhu, D., and W. G. Herrington. “In Adults with BMI ≥27 Kg/m2 and CVD, but without Diabetes, Semaglutide Reduced MACE, Regardless of Baseline HbA1c Level.” Annals of Internal Medicine, vol. 177, no. 11, American College of Physicians, 2024.

Chicago Style

Zhu, D, and WG Herrington. 2024. “In Adults with BMI ≥27 Kg/m2 and CVD, but without Diabetes, Semaglutide Reduced MACE, Regardless of Baseline HbA1c Level.” Annals of Internal Medicine 177 (11).
Share
Print

Access Document

Publisher copy:: 10.7326/annals-24-02457-jc

Authors

+ Zhu, D More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Clinical Trial Service Unit
Role:: Author
ORCID:: 0000-0002-8470-8430

+ Herrington, WG More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Clinical Trial Service Unit
Role:: Author
ORCID:: 0000-0003-1172-8243

Publisher:: American College of Physicians
Journal:: Annals of Internal Medicine More from this journal
Volume:: 177
Issue:: 11
Article number:: JC122
Place of publication:: United States
Publication date:: 2024-11-05
DOI:: 10.7326/annals-24-02457-jc
EISSN:: 1539-3704
ISSN:: 0003-4819
Pmid:: 39496170

Language:: English
Keywords:: cardiovascular diseases

nutrition

overweight

subgroup analysis

metabolic and endocrine

diabetes

HbA1c

heart failure

obesity

cardiovascular

body mass index

mortality

semaglutide

sodium-glucose cotransporter-2 inhibitors
Pubs id:: 2055229
Local pid:: pubs:2055229
Deposit date:: 2024-11-19

Terms of use

Copyright holder:: American College of Physicians.
Copyright date:: 2024
Rights statement:: © 2024 American College of Physicians.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP